Financials
Financial year 2025
Dr. Nora van Ardenne from Edegem, company number BE0650696190, closed financial year 2025 with a result of € 111,856 after tax. For that financial year Dr. Nora van Ardenne recorded a gross margin of € 175,529 and equity of € 18,600. Compared with financial year 2024, the result moved from € 135,934 to € 111,856. The company is profitable. The buffer shrank hard: equity is 88 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.
€ 18,600
▼ 88% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 111,856
▼ 18% vs 2024
Profit after tax over the fiscal year.
€ 249,922
▲ 11% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 249,650 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 41,751
▼ 22% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,564
Supplier invoices still open on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 128,831 | € 237,005 | € 207,859 | € 175,529 | ▼ 16% |
| Profit after taxes | € 86,814 | € 165,465 | € 135,934 | € 111,856 | ▼ 18% |
| Equity | € 107,274 | € 185,925 | € 156,394 | € 18,600 | ▼ 88% |
| Total debts | € 180,091 | € 148,830 | € 161,547 | € 295,494 | ▲ 83% |
| Cash | € 167,398 | € 82,010 | € 225,596 | € 249,922 | ▲ 11% |
| Retained profit | € 88,674 | € 167,325 | € 137,794 | € 0 | ▼ 100% |
| Dividend | € 0 | € 86,814 | € 165,465 | € 249,650 | ▲ 51% |
| Balance sheet total | € 287,364 | € 334,754 | € 317,940 | € 314,094 | ▼ 1% |
Key figures of Dr. Nora van Ardenne, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about Dr. Nora van Ardenne the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to Dr. Nora van Ardenne?
What happened at Dr. Nora van Ardenne in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 111,856 (▼ 18% vs 2024). Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Edegem. KBO
- Nora van Ardenne became a director. NBB
In short
From € 86,814 profit in 2022 to € 111,856 profit in 2025.
Paid € 145,376 in corporate taxes since 2022.
Best year ever: 2023, with € 165,465 profit.
Paid out € 501,928 in dividends to the owners in total.
Management
Behind Dr. Nora van Ardenne is Nora van Ardenne.
Directors
According to the 2025 annual accounts
Nora van Ardenne
Director
since 2016
Establishments
Establishment units
Physical locations of this company
Graaf de Fienneslaan 60
2650 Edegem
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- VAN ARDENNE Arnoldine Eleonore(oprichter) 100%
Details
- Company number
- 0650.696.190
- VAT number
- BE 0650.696.190
- Registered office
- Graaf de Fienneslaan 60, 2650 Edegem
- Names & denominations
- Dr. Nora van Ardenne
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 23 March 2016
- Peppol
- Active · Active since 27 Mar 2025